<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>DEV Community: Hyde Pritchard</title>
    <description>The latest articles on DEV Community by Hyde Pritchard (@stagekitty4).</description>
    <link>https://dev.to/stagekitty4</link>
    <image>
      <url>https://media2.dev.to/dynamic/image/width=90,height=90,fit=cover,gravity=auto,format=auto/https:%2F%2Fdev-to-uploads.s3.us-east-2.amazonaws.com%2Fuploads%2Fuser%2Fprofile_image%2F2728239%2Fc24c5bf4-8151-4674-bede-1a0e7499d346.png</url>
      <title>DEV Community: Hyde Pritchard</title>
      <link>https://dev.to/stagekitty4</link>
    </image>
    <atom:link rel="self" type="application/rss+xml" href="https://dev.to/feed/stagekitty4"/>
    <language>en</language>
    <item>
      <title>Medical Efficiency along with Security Report involving Anterior Thalamic Stimulation with regard to Intractable Epilepsy.</title>
      <dc:creator>Hyde Pritchard</dc:creator>
      <pubDate>Tue, 21 Jan 2025 10:31:54 +0000</pubDate>
      <link>https://dev.to/stagekitty4/medical-efficiency-along-with-security-report-involving-anterior-thalamic-stimulation-with-regard-h96</link>
      <guid>https://dev.to/stagekitty4/medical-efficiency-along-with-security-report-involving-anterior-thalamic-stimulation-with-regard-h96</guid>
      <description>&lt;p&gt;Background/Aims We present a case of 2 concomitant tumours, i.e., a sebaceous carcinoma (SC) and a small lymphocytic lymphoma (SLL), in the lacrimal gland of a patient with Muir-Torre syndrome. Methods Clinical history, orbital examination, diagnostic biopsy, excisional biopsy, and histopathologic analysis were utilized. Results An 89-year-old female presented to the eye casualty with corneal ulcer, anterior uveitis, proptosis, and restricted ocular motility. She has a clinical history of breast cancer, colon carcinoma, and SC of the eyelid, which had been resected completely 2 years before. Clinical examination, imaging, and diagnostic biopsy confirmed orbital SC recurrence. Exenteration and subsequent histopathologic analysis of the specimen revealed lymphocytic infiltrates consistent with SLL within the lacrimal gland. Conclusion We report for the first time a case of a patient with Muir-Torre syndrome who developed an orbital recurrent SC with an incidental finding of a lacrimal gland B non-Hodgkin lymphoma consistent with SLL. Clinicians should be aware of the possibility of this coexistence of multiple cancer types in patients with sebaceous carcinoma and Muir-Torre syndrome. Copyright © 2019 by S. Karger AG, Basel.Purpose To describe the occurrence of bilateral primary uveal melanoma in 2 patients with mutation on the gene encoding BRCA1-associated protein 1 (BAP1). Methods Retrospective chart review of patients with bilateral primary uveal melanoma and subsequent positive germline BAP1 mutation. Results There were 2 patients with bilateral uveal melanoma and BAP1 germline positivity. Neither patient demonstrated oculodermal melanocytosis. Patient 1 underwent enucleation of his right eye (OD) at the age of 44 years for a 9.6-mm-thick choroidal melanoma. He returned 4 years later with a 10.0-mm-thick choroidal melanoma in his left eye (OS) and was treated with plaque radiotherapy. He had a strong family history of cancer, and clinical testing for germline BAP1 mutation identified a pathogenic mutation in BAP1. At the 18-month follow-up, visual acuity was 20/200 OS without evidence of systemic metastasis. Patient 2 initially presented at age 54 years with extensive, diffuse iris melanoma OD, initially treated with plaque radiotherapy, but local recurrence after 3 years necessitated enucleation. Four years later, a 6.0-mm-thick ciliary body melanoma OS was found and successfully treated with plaque radiotherapy. Clinical testing for germline BAP1 mutation identified a pathogenic mutation in BAP1. At the 8-year follow-up, visual acuity was 20/40 OS without evidence of local recurrence or systemic metastasis. The patient expired secondary to an unrelated brain infarction. Conclusion Bilateral uveal melanoma is exceedingly rare. Patients with bilateral uveal melanoma, especially when coincident with remote systemic cancers or a family history of cancer, should be evaluated for germline BAP1 mutation. Lifelong monitoring for related systemic malignancies is advised. Copyright © 2019 by S. Karger AG, Basel.Objective To demonstrate the multimodal imaging and histopathology of Berger's space. Methods We conducted a retrospective in vivo analysis of 4 patients demonstrating Berger's space with intraocular pathological conditions, documented by slit-lamp biomicroscopic photography and, in 2 patients, also by optical coherence tomography (OCT). Additionally, we carried out a retrospective histological study of 7 enucleated eyes with retinoblastoma demonstrating Berger's space. A review of the literature was also performed. Results Two eyes had slit-lamp photographs. One case showed Berger's space surrounded by vitreous hemorrhage. In the other case, amyloid was trapped within Berger's space. In another 2 eyes that were pseudophakic, Berger's space was visible on anterior segment OCT. One had amyloid trapped in Berger's space that could be seen with OCT. The histological review of the 7 enucleated eyes with advanced retinoblastoma demonstrated the presence of pyknotic cells in Berger's space. Selleck Sodium Bicarbonate Conclusions Berger's space is an actual space in pathological conditions and can be an important site of pathology. Additionally, to our knowledge, this is the first time that Berger's space has been documented by anterior segment OCT in a clinical setting. Copyright © 2019 by S. Karger AG, Basel.Background The release of dopamine (DA) has certain roles in the induction of conditioned place preference (CPP) and motor learning in the ventral tegmental area (VTA). The aim of this study was to investigate the excitatory effects of DA through DA-D1 agonist (SKF38393) and elimination of the inhibitory effects of DA through DA-D2 antagonist (eticlopride) into the VTA and its synergistic effects with an ineffective dose of morphine in the induction of CPP. Materials and Methods Morphine (2.5 mg/kg; s. c.) did not induce a significant CPP, without any effect on the locomotor activity during the testing phase. SKF38393 (0.125, 0.5, and 1 μg/side) and eticlopride (0.5, 1, and 2 μg/side) individually or simultaneously were microinjected bilaterally into the VTA. Results The administration of SKF38393 (1 and 2 μg/rat) with ineffective morphine and also without morphine caused CPP on test day, while eticlopride (2 μg/rat) caused CPP with morphine only. Locomotor activity increased in groups receiving D1 agonist and D2 antagonist that presumed to be caused by the reinforcing effect. In addition, the concurrent administration of ineffective doses of D1 agonist and D2 antagonist into the VTA with ineffective morphine caused CPP but not with saline. Conclusions This study showed that there was a need for morphine to activate the reward circuit through the D2 receptor in the VTA while the administration of the D1 agonist could independently activate the reward circuit. In addition, there was a probable synergistic effect using ineffective doses of D1 and D2 receptors, in the acquisition of morphine-induced CPP. Copyright © 2019 Advanced Biomedical Research.Background Molgramostim, a nonglycosylated version of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), can be produced in a high level by Escherichia coli. However, overexpression of GM-CSF in bacterial cells usually leads to formation of inclusion bodies and insoluble protein aggregates which are not biologically active. The aim of the present study was to improve the expression of soluble and biologically active GM-CSF in periplasmic space of E. coli BL21 (DE3). Materials and Methods The codon-optimized GM-CSF gene was subcloned into pET-22b expression vector, in frame with the pelB secretion signal peptide for periplasmic secretion. Cultivation conditions including as isopropyl β-D-1-thiogalactopyranoside (IPTG) concentration, incubation temperature, and presence of sucrose were optimized to improve periplasmic expression of GM-CSF. The expressed protein was purified using Ni-NTA affinity column. Biological activity of GM-CSF on HL-60 cells was evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay.&lt;a href="https://www.selleckchem.com/products/sodium-bicarbonate.html" rel="noopener noreferrer"&gt;Selleck Sodium Bicarbonate&lt;/a&gt;&lt;/p&gt;

</description>
    </item>
    <item>
      <title>Corrigendum in order to 'Should management of low-level rifampicin mono-resistant t . b differ?Ha [JCTUBE 23 (2021) 100241].</title>
      <dc:creator>Hyde Pritchard</dc:creator>
      <pubDate>Sun, 19 Jan 2025 10:43:31 +0000</pubDate>
      <link>https://dev.to/stagekitty4/corrigendum-in-order-to-should-management-of-low-level-rifampicin-mono-resistant-t-b-differha-37hi</link>
      <guid>https://dev.to/stagekitty4/corrigendum-in-order-to-should-management-of-low-level-rifampicin-mono-resistant-t-b-differha-37hi</guid>
      <description>&lt;p&gt;If the patient undergoes surgical resection, we recommend careful effort to minimize trauma to the sigmoid sinus. Saracatinib price In addition, the surgeon may consider retrosigmoid or middle fossa approaches. Best practice recommendations include the use of pneumatic compression devices, early ambulation, and consideration of postoperative prophylactic anticoagulation in patients with a known genetic predisposition. &lt;br&gt;
In patients with a known propensity for venous thromboembolism, the skull base surgeon should consider nonsurgical management. If the patient undergoes surgical resection, we recommend careful effort to minimize trauma to the sigmoid sinus. In addition, the surgeon may consider retrosigmoid or middle fossa approaches. Best practice recommendations include the use of pneumatic compression devices, early ambulation, and consideration of postoperative prophylactic anticoagulation in patients with a known genetic predisposition. &lt;br&gt;
 Concomitant otosclerosis (OTS) and superior semicircular canal dehiscence (SSCD) is a rare, but difficult-to-identify and treat diagnosis. A systematic review of the literature was performed to analyze the diagnostic and therapeutic approaches of concurrent OTS and SSCD cases and to identify possible factors that may help in predicting the surgical outcome. &lt;/p&gt;

&lt;p&gt;PubMed, Scopus, Medscape, Ovid databases. &lt;/p&gt;

&lt;p&gt;Studies showing diagnosis of OTS documented by audiometric test with or without associated radiological signs (computed tomography), and concomitant diagnosis of SSCD, documented at least by high-resolution computed tomography (and possibly supported by neurophysiological testing) were included. Both surgically treated and untreated patients were considered for data analysis. &lt;/p&gt;

&lt;p&gt;The general characteristics of each study were recorded, when available. Clinical, audiological, vestibular testing, surgical, and radiological data were extracted from the published case reports and series, and recorded on a database. is possible with a proper interpretation of clinical signs, audiometric, and vestibular testing, in association with the radiologic assessment. Despite that the length and the location of the dehiscence may guide the surgical decision, definitive conclusions regarding the appropriate indications for surgical treatment cannot be drawn due to the limited number of cases with adequate data reported in the literature.A major ongoing challenge in sports medicine and the military is the determination of when an athlete or Military Service Member is ready to return-to-activity (RTA) after suffering an exertional heat stroke. A Heat Tolerance Test (HTT) is one method used for RTA assessment, but its test specificity is unknown and may be affected by heat acclimation (HA) status. &lt;br&gt;
 To characterize HTT specificity and determine any effect of HA on the outcome. &lt;/p&gt;

&lt;p&gt;Thirteen unacclimatized, healthy men (VO2peak43.0±4.8 ml/kg/min) with no prior history of heat illness completed 8 days of HA using the HTT protocol (40°C/40% RH; 120 minutes; 5 km/hour and 2% grade). Heart rate (HR) and core temperature (Tcore) recorded every 5 minutes during exercise and at the end of 120 minutes (terminal value) were compared between days 1 and 8. Test specificity (given no prior history of heat illness, the probability of being heat tolerant) was calculated on days 1 and 8. &lt;/p&gt;

&lt;p&gt;There was a significant reduction in HR and Tcore between days 1 and 8, indicating successful HA. All volunteers successfully completed 120 minutes of walking on all days. HTT specificity ranged between 54 and 85% on day 1 and 77 and 92% on day 8, depending on the HTT criteria used. &lt;/p&gt;

&lt;p&gt;Young healthy men without any prior heat illness experienced a 15 to 46% false positive fail rate for the HTT without HA. After HA, the false positive fail rate decreased to between 8 and 13%. Outcomes of the HTT are significantly affected by the criteria used and by HA status. Use of the HTT for RTA decisions should be done with recognition of these effects. &lt;br&gt;
Young healthy men without any prior heat illness experienced a 15 to 46% false positive fail rate for the HTT without HA. After HA, the false positive fail rate decreased to between 8 and 13%. Outcomes of the HTT are significantly affected by the criteria used and by HA status. Use of the HTT for RTA decisions should be done with recognition of these effects. &lt;br&gt;
 The study aimed to determine the impact of diurnal versus nocturnal exercise on gastrointestinal integrity and functional responses, plasma LBP and sCD14 concentrations (as indirect indicators of endotoxin responses), systemic inflammatory cytokine profile, gastrointestinal symptoms and feeding tolerance. &lt;/p&gt;

&lt;p&gt;Endurance runners (n=16) completed 3 h of 60% V˙O2max (22.7°C, 45% RH) running, on one occasion performed at 0900h (400-lux; DAY) and another occasion at 2100h (2-lux; NIGHT). Blood samples were collected pre- and post-exercise, and during recovery to determine plasma concentrations of cortisol, catecholamines, claudin-3, I-FABP, LBP and sCD14, and inflammatory cytokine profiles by ELISA. Orocecal transit time (OCTT) was determine by lactulose challenge test given at 150 min, with concomitant breath hydrogen (H2) and gastrointestinal symptoms (GIS) determination. &lt;/p&gt;

&lt;p&gt;Cortisol increased substantially pre- to post-exercise on NIGHT (+182%) versus DAY (+4%) (trial×time, p=0.046), with no epinephrine (+41%) annd controlled procedures. &lt;br&gt;
Nocturnal exercise instigates greater gastrointestinal functional perturbations and symptoms compared to diurnal exercise. Although there are no circadian differences to gastrointestinal integrity and systemic perturbations in response to the same exertional stress and controlled procedures. &lt;br&gt;
 Although scoliosis is a 3-dimensional (3D) deformity, little research has been performed on the use of 3D imaging in brace curve correction. The purpose of the present study was to determine the effect of axial-plane parameters on the outcomes of bracing with a thoracolumbosacral orthosis for adolescent idiopathic scoliosis. &lt;/p&gt;

&lt;p&gt;This prospective longitudinal cohort study included patients with adolescent idiopathic scoliosis who fulfilled the criteria for bracing according to the Scoliosis Research Society, and was conducted from the time the patient began wearing the brace through a minimum follow-up of 2 years or until a surgical procedure was performed. Radiographs made with use of an EOS Imaging System were used to reconstruct 3D images of the spine at the pre-brace, immediate in-brace, 1-year in-brace, and latest follow-up out-of-brace stages. Univariate and multiple linear regressions were performed to determine the association between axial rotation correction and curve progression at the time of the latest follow-up.&lt;a href="https://www.selleckchem.com/products/AZD0530.html" rel="noopener noreferrer"&gt;Saracatinib price&lt;/a&gt;&lt;/p&gt;

</description>
    </item>
  </channel>
</rss>
